Fortis Healthcare launches Fortis Institute of Genomic Medicine
Genomics is transforming the future of modern medicine and treatment modalities across specialties
Genomics is transforming the future of modern medicine and treatment modalities across specialties
The plant will have installed production capacity of 3,120 MT/month
The approved product, Mesalamine Suppositories 1000 mg, has an estimated U.S. market size of US$ 29 million
Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Strengthening capabilities in Peptide Therapeutics and CDMO services
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Subscribe To Our Newsletter & Stay Updated